FTLOScience
FTLOScience

Articles by Marina

Demystifying AI in Drug Discovery: Chemical Synthesis

How can we use artificial intelligence (AI) to improve drug discovery and development? In this installment of our deep dive, we describe how AI and machine learning (ML) can improve chemical synthesis R&D, an area of drug development where pharmaceutical companies have struggled with in recent years. We also introduce several startups using AI to plan and automate chemical synthesis. […]

Demystifying AI in Drug Discovery: Primary and Secondary Screening

How can we use artificial intelligence (AI) to improve drug discovery and development? In this installment of our deep dive, we walk you through how AI can accelerate primary and secondary screening during the drug discovery stage. We also introduce several startups using artificial intelligence and machine learning tools to create new medicines. […]

By |February 12, 2023|Categories: Structure-Based Design|Tags: , , , |
marina ftloscience writer
Marina Alamanou PhD
Science Writer

Marina is a molecular and cellular biologist, writer and a bit of an intellectual still trying to fit in. She has 20+ years of experience in academia, startups and multinationals. Currently is a life science consultant. She writes about A.I., drug discovery, biotech and science.

Go to Top